UMTA.F Stock Overview
Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Genertec Universal Medical Group Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.59 |
| 52 Week High | HK$0.67 |
| 52 Week Low | HK$0.50 |
| Beta | 0.73 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -0.83% |
| 3 Year Change | -0.83% |
| 5 Year Change | -27.44% |
| Change since IPO | -28.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| UMTA.F | US Diversified Financial | US Market | |
|---|---|---|---|
| 7D | 0% | -4.1% | -3.5% |
| 1Y | -0.8% | 19.5% | 20.2% |
Return vs Industry: UMTA.F underperformed the US Diversified Financial industry which returned 16.5% over the past year.
Return vs Market: UMTA.F underperformed the US Market which returned 15.2% over the past year.
Price Volatility
| UMTA.F volatility | |
|---|---|
| UMTA.F Average Weekly Movement | n/a |
| Diversified Financial Industry Average Movement | 5.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: UMTA.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine UMTA.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 20,077 | Wang Wenbing | www.umcare.cn |
Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People’s Republic of China. It operates in two segments, Finance and Advisory and Hospital Group. The Finance and Advisory segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services.
Genertec Universal Medical Group Company Limited Fundamentals Summary
| UMTA.F fundamental statistics | |
|---|---|
| Market cap | US$1.16b |
| Earnings (TTM) | US$275.19m |
| Revenue (TTM) | US$1.68b |
4.2x
P/E Ratio0.7x
P/S RatioIs UMTA.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| UMTA.F income statement (TTM) | |
|---|---|
| Revenue | CN¥11.57b |
| Cost of Revenue | CN¥7.43b |
| Gross Profit | CN¥4.14b |
| Other Expenses | CN¥2.25b |
| Earnings | CN¥1.89b |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.00 |
| Gross Margin | 35.79% |
| Net Profit Margin | 16.34% |
| Debt/Equity Ratio | 233.7% |
How did UMTA.F perform over the long term?
See historical performance and comparison